Going beyond small-sample payer interviews: Reliable and quantitative value pricing research

Speaking to just a handful of payers risks your price strategy suffering from unreliable wide-ranging price responses. Price strategies rely on quantitative metrics, and quantitative metrics must be powered with reliable respondent sample sizes. However, payers can be difficult to recruit into research projects, especially outside of the US. This article investigates what constitutes a reliable payer sample.

Back to White Papers

Download the document by filling in the form:

By clicking on the “Submit Request” button you are providing consent for us to store your data and contact you. You may withdraw your consent at any time by instructing us at .

View our Privacy Policy for more information.

Please note that Inpharmation literature and case study materials constitute Inpharmation intellectual property and are intended for the pharmaceutical industry. Inpharmation is under no obligation to distribute these materials to non-pharmaceutical industry employees or competitors.

Scroll Top